Ligand Avinza indication (correction)
Ligand's extended-release morphine product Avinza is approved for p.m. as well as daytime use. The drug "is not intended for use as a p.r.n. analgesic," labeling states (1"The Pink Sheet" March 25, p. 23)...
You may also be interested in...
Ligand will focus on Avinza once-daily dosing as the opioid's primary marketing message following the March 20 approval of the extended-release morphine drug licensed from Elan
When asked about an inspector general report that found hospitals are struggling with tests and resources, and are looking to the federal government to help facilitate more efficient distribution of medical devices to fight the COVID-19 crisis, President Trump attacked the report as a political hit from an Obama holdover.
Japanese medical device manufacturer Terumo Corp. promoted senior management execs; MiMedx Group, developer of human placental tissue allografts, raised exec to CFO; and more.